These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17448822)

  • 1. Eradication versus control for poliomyelitis: an economic analysis.
    Thompson KM; Tebbens RJD
    Lancet; 2007 Apr; 369(9570):1363-1371. PubMed ID: 17448822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic analysis of the global polio eradication initiative.
    Duintjer Tebbens RJ; Pallansch MA; Cochi SL; Wassilak SG; Linkins J; Sutter RW; Aylward RB; Thompson KM
    Vaccine; 2010 Dec; 29(2):334-43. PubMed ID: 21029809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risks, costs, and benefits of possible future global policies for managing polioviruses.
    Thompson KM; Tebbens RJ; Pallansch MA; Kew OM; Sutter RW; Aylward RB; Watkins M; Gary HE; Alexander J; Jafari H; Cochi SL
    Am J Public Health; 2008 Jul; 98(7):1322-30. PubMed ID: 18511720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs and benefits of polio eradication: a long-run global perspective.
    Khan MM; Ehreth J
    Vaccine; 2003 Jan; 21(7-8):702-5. PubMed ID: 12531344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective cost-effectiveness analyses for polio vaccination in the United States.
    Thompson KM; Tebbens RJ
    Risk Anal; 2006 Dec; 26(6):1423-40. PubMed ID: 17184390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost analysis of post-polio certification immunization policies.
    Sangrujee N; Cáceres VM; Cochi SL
    Bull World Health Organ; 2004 Jan; 82(1):9-15. PubMed ID: 15106295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The costs of future polio risk management policies.
    Tebbens RJ; Sangrujee N; Thompson KM
    Risk Anal; 2006 Dec; 26(6):1507-31. PubMed ID: 17184394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global eradication of poliomyelitis: benefit-cost analysis.
    Bart KJ; Foulds J; Patriarca P
    Bull World Health Organ; 1996; 74(1):35-45. PubMed ID: 8653814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease eradication as a public health strategy: a case study of poliomyelitis eradication.
    Aylward RB; Hull HF; Cochi SL; Sutter RW; Olivé JM; Melgaard B
    Bull World Health Organ; 2000; 78(3):285-97. PubMed ID: 10812724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential benefits of a new poliovirus vaccine for long-term poliovirus risk management.
    Duintjer Tebbens RJ; Thompson KM
    Future Microbiol; 2016 Dec; 11():1549-1561. PubMed ID: 27831742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
    Orenstein WA;
    Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of alternative polio immunization policies in South Africa.
    Griffiths UK; Botham L; Schoub BD
    Vaccine; 2006 Jul; 24(29-30):5670-8. PubMed ID: 16766096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economics of polio vaccination in the post-eradication era: should OPV-using countries adopt IPV?
    Khan MM
    Vaccine; 2008 Apr; 26(16):2034-40. PubMed ID: 18339460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of polio eradication.
    Hull HF
    Lancet Infect Dis; 2001 Dec; 1(5):299-303. PubMed ID: 11871802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for eradication of poliomyelitis--the Indian experience.
    Banerjee K; Sahu S; Sarkar S
    Indian J Public Health; 2000; 44(1):5-14. PubMed ID: 11439860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and consideration of global policies for managing the future risks of poliovirus outbreaks: insights and lessons learned through modeling.
    Thompson KM; Duintjer Tebbens RJ; Pallansch MA; Kew OM; Sutter RW; Aylward RB; Watkins M; Gary H; Alexander JP; Venczel L; Johnson D; Cáceres VM; Sangrujee N; Jafari H; Cochi SL
    Risk Anal; 2006 Dec; 26(6):1571-80. PubMed ID: 17184398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensified pulse polio immunization: time spent and cost incurred at a primary healthcare centre.
    Yadav K; Rai SK; Vidushi A; Pandav CS
    Natl Med J India; 2009; 22(1):13-7. PubMed ID: 19761152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling strategies to increase population immunity and prevent poliovirus transmission in 2 high-risk areas in northern India.
    Kalkowska DA; Duintjer Tebbens RJ; Thompson KM
    J Infect Dis; 2014 Nov; 210 Suppl 1():S398-411. PubMed ID: 25316861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress towards global polio eradication.
    Hull HF
    Dev Biol (Basel); 2001; 105():3-7. PubMed ID: 11763334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.